SciClone Pharmaceuticals, Inc. (SCLN) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - Specialty & Generic industria.
SCLN tiene fecha de IPO 1992-03-17, cotiza en el NASDAQ.
SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company acquires, develops, and commercializes drugs for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.
